The impact of Daily Dosing on Clinical Efficacy
Evidence-led white paper derived from the 2024 peer-reviewed Wiley paper on the AC clinical trial.
Executive Summary
This white paper asks a practical and commercially important question: does taking a Collagen supplement every day matter, or is every-other-day use enough? The trial provides unusually direct evidence on this point because it compared daily use with every-48-hours use in parallel cohorts. Daily use was significantly superior for collagen fragmentation, wrinkle depth, and skin tone. By week 12, fragmentation fell 44.6% with daily use versus 10.6% with every-48-hours use (p < 0.01), and wrinkle Rz fell 19.7% versus 12.5% (p < 0.01). Skin tone evenness also favoured daily use (31.9% versus 26.3%, p = 0.03).
Not every endpoint is separated according to dosage regimen. Elasticity improved in both active regimens, but the difference between daily use and every-48-hours use was not statistically significant (22.7% versus 18.6%, p = 0.68). That nuance matters. The strongest evidence-based conclusion is that daily dosing delivered materially better outcomes for some of the most important structural and visible skin endpoints, even if not every measure showed a statistically meaningful gap.
Key Outcomes
| Metric | Result | What it means | |
|---|---|---|---|
| Collagen fragmentation | Collagen fragmentation | Daily use: -44.6%; every-48-hours use: -10.6% (p < 0.01). | Structural collagen improvement was substantially stronger with everyday dosing. |
| Wrinkle depth | Wrinkle depth | Daily use: -19.7%; every-48-hours use: -12.5% (p < 0.01). | Visible wrinkle benefit was stronger when the regimen was not diluted. |
| Skin tone evenness | Skin tone evenness | Daily use: -31.9%; every-48-hours use: -26.3% (p = 0.03). | Pigmentation distribution also favoured daily use, though the effect size gap was smaller. |
Study Snapshot
| | | |
|---|---|---|
| Study design | Study design | Randomised, double-blind, placebo-controlled 12-week clinical trial run under Good Clinical Practice. |
| Participants | Participants | 140 adults enrolled, 130 completed; age 40-60 years; Fitzpatrick I-VI; 90% female / 10% male. |
| Intervention | Intervention | Absolute Collagen supplement providing 8000 mg hydrolysed marine collagen plus 60 mg vitamin C, taken daily or every 48 hours. |
| Core assessments | Core assessments | Confocal microscopy and high-resolution ultrasound of collagen fibers, corneometer hydration, cutometer elasticity, profilometry of wrinkles, expert visual grading, trichoscopy, and self-perception questionnaires. |
Scientific Angle
A highly ownable angle in the evidence base is not simply that the product works, but that the dosing regimen materially affects outcome strength on several clinically relevant endpoints. It is the first published evidence that daily use of a hydrolysed collagen supplement delivers more skin benefits than use every 48 hours.
Discussion
This is one of the most strategically useful outputs in the trial because dosing questions are common, practical, and commercially relevant. Consumers often change regimen for convenience or cost reasons, but evidence on the efficacy consequences is usually absent. Here, the data allow a disciplined answer: reducing frequency appears to reduce benefit on several endpoints that matter most to visible skin quality.
The fragmentation finding is especially important because it links adherence to a mechanistically meaningful outcome. If daily use generates a far larger reduction in collagen fragmentation than alternate-day use, then regimen is not a minor implementation detail; it is part of the efficacy story. That is far more credible than generic adherence messaging because it is grounded in endpoint data.
The nuance on elasticity strengthens rather than weakens the overall paper. It shows that the right scientific message is selective, not absolute. Daily use was clearly better on some outcomes, but not all. That is exactly the kind of disciplined framing that makes the broader conclusion more trustworthy.
Limitations and Evidence Discipline
- The every-48-hours cohorts were smaller than the daily-use cohorts, which may reduce precision for some comparisons.
- Not all endpoints showed significant separation between dosing regimens.
- The trial does not test frequencies lower than every 48 hours or partial-dose strategies.
Conclusion
“The evidence supports a clear operational message: if the goal is maximal clinical effect, daily use matters. In this study, every-other-day use delivered weaker results on several of the endpoints that best define visible skin quality.”
Source note: derived from the peer-reviewed 2024 clinical paper only; no unsupported external claims have been added.
Reilly, David M., Kynaston, Liane, Naseem, Salma, Proudman, Eva, Laceby, Darcy, A Clinical Trial Shows Improvement in Skin Collagen, Hydration, Elasticity, Wrinkles, Scalp, and Hair Condition following 12-Week Oral Intake of a Supplement Containing Hydrolysed Collagen, Dermatology Research and Practice, 2024, 8752787, 12 pages, 2024. https://doi.org/10.1155/2024/8752787